Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Regen BioPharma (RGBP) Preferred Shares (2016 - 2025)

Historic Preferred Shares for Regen BioPharma (RGBP) over the last 11 years, with Q4 2025 value amounting to $1011.0.

  • Regen BioPharma's Preferred Shares changed 0.0% to $1011.0 in Q4 2025 from the same period last year, while for Dec 2025 it was $1011.0, marking a year-over-year change of 0.0%. This contributed to the annual value of $1011.0 for FY2025, which is 0.0% changed from last year.
  • Per Regen BioPharma's latest filing, its Preferred Shares stood at $1011.0 for Q4 2025, which was down 0.0% from $1011.0 recorded in Q3 2025.
  • In the past 5 years, Regen BioPharma's Preferred Shares ranged from a high of $60865.0 in Q4 2022 and a low of $40.0 during Q1 2023
  • For the 5-year period, Regen BioPharma's Preferred Shares averaged around $19414.7, with its median value being $1011.0 (2024).
  • Per our database at Business Quant, Regen BioPharma's Preferred Shares tumbled by 9993.43% in 2023 and then soared by 242750.0% in 2024.
  • Regen BioPharma's Preferred Shares (Quarter) stood at $43929.0 in 2021, then skyrocketed by 38.55% to $60865.0 in 2022, then plummeted by 99.93% to $40.0 in 2023, then surged by 2427.5% to $1011.0 in 2024, then changed by 0.0% to $1011.0 in 2025.
  • Its last three reported values are $1011.0 in Q4 2025, $1011.0 for Q3 2025, and $1011.0 during Q2 2025.